Core Insights - Dongbao Bio (300239.SZ) reported its Q3 2025 results, revealing that as of October 28, 2025, seven institutional investors held a total of 205 million shares, representing 34.59% of the company's total equity. This marks a decrease of 0.48 percentage points in institutional ownership compared to the previous quarter [1] Institutional Holdings - The institutional investors include Qingdao Guoen Technology Co., Ltd., Hainan Bainashengyuan Technology Co., Ltd., Shaanxi International Trust Co., Ltd. - Shaanguo Investment Dongbao Bio 2022 Employee Stock Ownership Trust Plan, National Social Security Fund 504 Portfolio, China Lucky Group Co., Ltd., Zhongke Xianxing (Beijing) Asset Management Co., Ltd., and Industrial and Commercial Bank of China - GF Jufeng Mixed Securities Investment Fund [1] - The total institutional ownership decreased by 0.48 percentage points from the last quarter [1] Public Fund Holdings - One public fund, GF Jufeng Mixed A, increased its holdings during this period, with an increase ratio of 0.29% [1] - A total of 35 public funds did not disclose their holdings this quarter, including Zhongzheng 2000, Huitianfu Zhongzheng 500 Index Enhanced A, Jiashi Zhongzheng Vaccine and Biotechnology ETF, GF Consumer Selected Mixed A, and Bodao Consumer Intelligent Navigation A [1] Social Security Fund Holdings - One social security fund, the National Social Security Fund 504 Portfolio, reduced its holdings by 0.58% compared to the previous quarter [1]